EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Social cognition and decision‐making in people with methamphetamine use disorder

Justin Mahlberg iD, Lauren Hanegraaf, Josua Zimmermann, David M Cole, Boris B Quednow iD, Shalini Arunogiri iD, Antonio Verdejo-Garcia iD

Addiction · 2025

DOI: 10.1111/add.70108 ↗

At a glance

Journal article in Addiction, 2025. Written by Justin Mahlberg and 6 co-authors. Institution: School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Clayton, Australia. Major MEDLINE topics: Decision Making, Amphetamine-Related Disorders, Methamphetamine, Social Cognition. Cited 6 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical research Future Fund, National Health and Medical Research Council Investigator, National Health and Medical Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Impairments in social cognition and social decision‐making play an important role in the disease burden experienced by individuals with methamphetamine use disorder (MUD). They are also assumed to play a role in the vicious cycle of MUD development and hinder its successful psychotherapy. However, research typically focuses on examining specific types of social cognitive deficits in MUD, rather than profiling the multidimensional social cognition and decision‐making impairments that coincide with MUD. Our study, thus, estimated the socio‐cognitive and social decision‐making profile of people with MUD and compared this profile with a methamphetamine‐naïve control group.

Design

Cross‐sectional case–control comparison of social cognition and decision‐making between participants with MUD recruited from clinical services and methamphetamine‐naïve controls (CTRL) recruited from the community.

Setting

Drug treatment clinics in Melbourne, Australia.

Participants

52 participants with MUD (moderate or severe; 77% identified as male) between April 2019 and September 2021 and 51 demographically matched CTRLs (no history of methamphetamine use; 54% identified as male) between May and September of 2021.

Measurements

We implemented a social cognition battery that assessed a participant's sensitivity for perceiving emotion from faces (emotion recognition) and their ability to detect accurately the emotional state of others (cognitive empathy) and experience the emotions of others (emotional empathy). We also characterised the propensity to engage in higher‐order social decision‐making by assessing a participant's willingness to engage in interpersonal trust and aggression in experimental simulations.

Findings

Compared with matched controls, people with MUD had a bias toward perceiving happier facial expressions as neutral [Estimate = −5.05, standard error (SE) = 2.05, P = 0.016, 95% confidence interval (95% CI) = (−9.12 to −0.98)], showing lower sensitivity to perceiving happy emotions [Estimate = −6.34, SE = 3.09, P = 0.043, 95% CI = (−12.47 to −0.20)]. People with MUD also showed a propensity to enact more intense punishments [Estimate = 1.48, SE = 0.38, P < 0.001, 95% CI = (0.73–2.23)] and lower levels of trust to others in their decisions [Estimate = −0.11, SE = 0.04, P = 0.002, 95% CI = (−0.18 to −0.04)].

Conclusions

In a clinical research study, people with methamphetamine use disorder appeared to show lower sensitivity to happy emotions, reduced trust and increased aggression toward others, relative to a matched control group.

Subjects

MeSH terms (MEDLINE)

Decision MakingAmphetamine-Related DisordersMethamphetamineSocial CognitionHumansMaleFemaleAdultCross-Sectional StudiesCase-Control StudiesMiddle AgedEmotionsAustralia

Author keywords

aggressiondecision‐makingemotionsempathymethamphetaminesocial cognitiontrust

Substances

Methamphetamine

Authors and institutions

  • School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Clayton, Australia.
  • Experimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.
  • Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland.
  • Translational Psychiatry Lab, University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland.
  • Monash Addiction Research Centre, Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Turning Point, Eastern Health, Melbourne, Australia.

ORCID profiles: Justin Mahlberg, Boris B Quednow, Shalini Arunogiri, Antonio Verdejo-Garcia

Funding

  • Medical research Future Fund
  • National Health and Medical Research Council Investigator
  • National Health and Medical Research Council

Cite

APA

Mahlberg, J., Hanegraaf, L., Zimmermann, J., Cole, D. M., Quednow, B. B., Arunogiri, S., & Verdejo-Garcia, A. (2025). Social cognition and decision‐making in people with methamphetamine use disorder. Addiction. https://doi.org/10.1111/add.70108

Vancouver

Mahlberg J, Hanegraaf L, Zimmermann J, Cole DM, Quednow BB, Arunogiri S, et al. Social cognition and decision‐making in people with methamphetamine use disorder. Addiction. 2025. doi:10.1111/add.70108

BibTeX
@article{Mahlberg2025,
  author = {Mahlberg, Justin and Hanegraaf, Lauren and Zimmermann, Josua and Cole, David M and Quednow, Boris B and Arunogiri, Shalini and Verdejo-Garcia, Antonio},
  title = {Social cognition and decision‐making in people with methamphetamine use disorder},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.70108}
}
Start for free →